1. Corrigendum to "P25 - Accessing mammalian drug metabolites using PolyCYPs® enzymes" [Drug Metabol Pharmacokinet 35 (2020) S29]. Issue 5 (October 2020) Authors: Lai, Sandie; Hodds, William; Poon, Vincent; Nytko, Kinga; Khan, Aksana; Hopkins, Emily; de Riso, Antonio; Phipps, Richard; Steele, Jonathan; Wrigley, Stephen; Evans, Liam; Scheffler, Frank; Shanu-Wilson, Julia Journal: Drug metabolism and pharmacokinetics Issue: Volume 35:Issue 5(2020) Page Start: 483 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P10 - Use of microbial biotransformation to produce scalable quantities of a glucuronidated metabolite of the clinical-stage soluble guanylate cyclase inhibitor praliciguat. (2020) Authors: Shanu-Wilson, Julia; Steele, Jonathan; Phipps, Richard; Manohar, Ravi; Karunakaran, Deepa; Borowik, Alicja; Scheffler, Frank; Evans, Liam; Carvalho, Andrew; Banijamali, Ali Journal: Drug metabolism and pharmacokinetics Issue: Volume 35(2020)Supplement 1 Page Start: S25 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P25 - Accessing mammalian drug metabolites using PolyCYPs® enzymes. (2020) Authors: Shanu-Wilson, Julia; Hodds, William; Lai, Sandie; Phipps, Richard; de Riso, Antonio; Poon, Vincent; Nytko, Kinga; Khan, Aksana; Evans, Liam; Scheffler, Frank; Steele, Jonathan Journal: Drug metabolism and pharmacokinetics Issue: Volume 35(2020)Supplement 1 Page Start: S29 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗